(Q37590925)

English

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials

scientific article published on 31 August 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 August 2017

1 reference

Europe PubMed Central

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials (English)

1 reference

Europe PubMed Central

21 August 2017

1 reference

based on heuristic

inferred from title

Eugene Braunwald

2

object named as

Eugene Braunwald

1 reference

Europe PubMed Central

21 August 2017

Elliott M Antman

3

object named as

Elliott M Antman

1 reference

Europe PubMed Central

21 August 2017

Raymond W M Hautvast

8

object named as

Raymond W Hautvast

1 reference

Europe PubMed Central

21 August 2017

Marc S Sabatine

13

object named as

Marc S Sabatine

1 reference

Europe PubMed Central

21 August 2017

Sabina A Murphy

4

object named as

Sabina A Murphy

1 reference

Europe PubMed Central

21 August 2017

Stephen D Wiviott

14

object named as

Stephen D Wiviott

1 reference

Europe PubMed Central

21 August 2017

Jessica L. Mega

12

object named as

Jessica L Mega

1 reference

Europe PubMed Central

21 August 2017

10

object named as

Sandra L Close

1 reference

Europe PubMed Central

21 August 2017

Michelle L O'Donoghue

1

object named as

Michelle L O'Donoghue

1 reference

Europe PubMed Central

21 August 2017

Alan D Michelson

7

object named as

Alan D Michelson

1 reference

Europe PubMed Central

21 August 2017

author name string

Eric R Bates

5

1 reference

Europe PubMed Central

21 August 2017

Yoseph Rozenman

6

1 reference

Europe PubMed Central

21 August 2017

Peter N Ver Lee

9

1 reference

Europe PubMed Central

21 August 2017

Lei Shen

11

1 reference

Europe PubMed Central

21 August 2017

language of work or name

0 references

publication date

31 August 2009

1 reference

Europe PubMed Central

21 August 2017

1 reference

Europe PubMed Central

21 August 2017

374

1 reference

Europe PubMed Central

21 August 2017

989-997

1 reference

Europe PubMed Central

21 August 2017

9694

1 reference

Europe PubMed Central

21 August 2017

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961525-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961525-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myoc

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961525-7

7 January 2021

based on heuristic

inferred from DOI database lookup

ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961525-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961525-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961525-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961525-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A population-based study of the drug interaction between proton pump inhibitors and clopidogrel

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961525-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961525-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prasugrel versus clopidogrel in patients with acute coronary syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961525-7

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961525-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytochrome p-450 polymorphisms and response to clopidogrel

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961525-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961525-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961525-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961525-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961525-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic determinants of response to clopidogrel and cardiovascular events

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961525-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961525-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961525-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961525-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syndromes taking atorvastatin versus other statin therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961525-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stenting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961525-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961525-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(09)61525-7

1 reference

Europe PubMed Central

21 August 2017

1 reference

Europe PubMed Central

21 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37590925&oldid=1744723463"